Ethambutol 400mg tablets

Šalis: Didžioji Britanija

kalba: anglų

Šaltinis: MHRA (Medicines & Healthcare Products Regulatory Agency)

Veiklioji medžiaga:

Ethambutol hydrochloride

Prieinama:

DE Pharmaceuticals

ATC kodas:

J04AK02

INN (Tarptautinis Pavadinimas):

Ethambutol hydrochloride

Dozė:

400mg

Vaisto forma:

Oral tablet

Vartojimo būdas:

Oral

Klasė:

No Controlled Drug Status

Recepto tipas:

Valid as a prescribable product

Produkto santrauka:

BNF: 05010900

Pakuotės lapelis

By reporting side effects you can help provide more information on
the safety of this medicine.
Play or Apple App Store.
Intrapharm Laboratories Ltd., The Courtyard Barns, Choke Lane,
Maidenhead, Berks SL6 6PT, UK
Intrapharm Laboratories Ltd., The Courtyard Barns, Choke Lane,
Maidenhead, Berks SL6 6PT, UK
280.00 mm
150.00 mm

Prekės savybės

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ethambutol 400 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film coated tablet contains 400mg Ethambutol Hydrochloride.
For a full list of excipients see section 6.1.
3
PHARMACEUTICAL FORM
Film coated tablet.
Smooth, grey, circular, biconvex film coated tablet, plain on both
sides.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
The primary treatment and re-treatment of tuberculosis and for
prophylaxis in cases
of inactive tuberculosis or large-tuberculinpositive reaction.
Ethambutol should only
be used in conjunction with other anti-tuberculous drugs to which the
patient’s
organisms are susceptible.
Consideration
should
be
given
to
official
guidance
on
the
appropriate
use
of
antibacterial agents
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Route of administration_:
Oral
_Posology: _
Recommended Dosage
The dosage of ethambutol must be adjusted according to the body weight
of the
patient.
This drug should not be used as a sole anti-tuberculosis agent, but
should be given
with at least one other antituberculosis drug to avoid development of
resistant strains.
The usual daily dosage is 15-25mg/kg body weight given as a single
dose.
_ _
_ADULTS _
For primary treatment and prophylaxis: Ethambutol should be
administered in a
single
daily
dose
of
15mg/kg,
concomitant
drugs
being
maintained
at
their
recommended dosage levels.
For
re-treatment:
For
the
first
60
days
of
treatment,
ethambutol
should
be
administered in a single daily dose of 25mg/kg. Thereafter the dosage
should be
reduced to 15mg/kg, concomitant drugs being maintained at their
recommended
dosage levels.
_ _
_CHILDREN _
For primary treatment and re-treatment: For the first 60 days of
treatment, a single
daily oral dose of 25mg/kg. Thereafter the dosage should be reduced to
15mg/kg,
concomitant drugs being maintained at their recommended dosage
levels._ _
For prophylaxis: A single daily oral dose of 15mg/kg, concomitant
drugs being used
at their recommended dosage levels
As ch